How a Brazilian Snake's Venom Led to a Widely Used Blood Pressure Drug

Scientific research conducted in the 1960s on the venom of the Brazilian pit viper, *Bothrops jararaca*, contributed to the development of captopril, one of the first widely used blood pressure medications approved in the United States in 1981.

Published reports and historical scientific findings indicate that studying natural toxins can help guide the discovery of new pharmacological treatments. This article outlines how researchers traced venom compounds to cardiovascular therapeutics, emphasizing that raw venom is not a substitute for prescribed medications.

The Discovery in Snake Venom

In 1965, Brazilian pharmacologist Sergio Ferreira published research detailing a venom extract that enhanced the effects of bradykinin, a peptide that widens blood vessels and lowers blood pressure. Subsequent investigations identified bradykinin-potentiating peptides in the venom.

Researchers focused on the angiotensin-converting enzyme (ACE), which typically converts angiotensin I into angiotensin II (a blood vessel constrictor) and breaks down bradykinin.

From Venom Peptide to Medicine

• Initial peptide studies: Researchers found that the venom-derived peptide teprotide could inhibit ACE and lower blood pressure.
• Practical limitations: Teprotide could not be administered orally, prompting the search for a compound suitable for tablet form.
• Regulatory approval: Captopril emerged as an orally active ACE inhibitor and received approval from the United States Food and Drug Administration in 1981.

Practical Implications and Verification

• Hypertension management: High blood pressure strains the heart and blood vessels; medications like captopril target these regulatory biological processes.
• Clinical applications: ACE inhibitors are utilized for hypertension, certain cases of heart failure, and kidney disease based on individual patient assessments.
• Safety distinction: The research highlights natural biological clues, but raw snake venom is never a replacement for prescribed medical treatments.

Readers can verify historical pharmacological developments by reviewing peer-reviewed journals such as the *British Journal of Pharmacology* and regulatory documentation from the U.S. FDA.